Live Breaking News & Updates on Treating Advanced

Stay updated with breaking news from Treating advanced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Patritumab Deruxtecan (HER3-DXd) in Patients with EGFR Mutation-Positive Advanced NSCLC

Dr. Gadgeel reviews the HERTHENA-Lung01 trial results of the HER3 targeting antibody drug conjugate patritumab deruxtecan in EGFR-positive non-small cell lung cancer. ....

Antibody Drug Conjugates , Treating Advanced , Positive Advanced , Lung Cancer , Non Small Cell Lung Cancer ,

Sacituzumab Govitecan + Pembrolizumab in First-Line Metastatic NSCLC

Dr. Shirish Gadgeel discusses recent EVOKE-2 trial results showing promising response rates with sacituzumab govitecan combined with pembrolizumab for metastatic non-small cell lung cancer. ....

Sacituzumab Govitecan , Antibody Drug Conjugates , Treating Advanced , First Line Metastatic , Lung Cancer , Non Small Cell Lung Cancer ,

Dato-DXd for Treating Advanced NSCLC

Benjamin Levy, MD, reviews clinical data on Dato-DXd in patients with advanced NSCLC and their practical implications. ....

Benjamin Levy , Antibody Drug Conjugates , Treating Advanced , Lung Cancer , Non Small Cell Lung Cancer ,

T-DXd in HER2 Mutated Advanced NSCLC

Benjamin Levy, MD, reviews clinical data on T-DXd in HER2 mutated advanced NSCLC and their practical implications. ....

Benjamin Levy , Antibody Drug Conjugates , Treating Advanced , Lung Cancer , Non Small Cell Lung Cancer ,

Molecular Testing in Advanced NSCLC

Benjamin Levy, MD, discusses the role of molecular testing in patients with advanced NSCLC. ....

Benjamin Levy , Antibody Drug Conjugates , Treating Advanced , Lung Cancer , Non Small Cell Lung Cancer ,